UGDH and ovarian carcinoma: Interestingly, in ovarian cancer, UGDH KD has been shown to negatively regulate levels of activated (phosphorylated) ERK with direct impacts on expression of MMP-2, MMP-9 and EMT-related factors further downstream [3].